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tively associated with the skin prick reactivity, mite-specific 
IgE and the ratio IgE/IgG4 in the high-transmission village. 
However, when only low levels of infection were analyzed in 
the 2 villages, there was no correlation between mite-specif-
ic responses and infection intensity.  Conclusion: The rela-
tionship between schistosome infection and atopic respons-
es is dependent on the intensity of current schistosome in-
fection. Thus, consistent with results from animal models, 
with an increasing parasite burden, the immunoregulation 
of immune responses to allergens appears to become more 
pronounced.  Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Atopy, i.e. the genetic predisposition to become IgE-
sensitized to environmental allergens  [1] , is an important 
risk factor for allergic diseases but only a small propor-
tion of atopic individuals develop clinical symptoms
 [2, 3] . The clinical manifestation of allergic symptoms in 
atopic individuals is influenced by environmental factors 
such as air pollution, diet and exposure to pathogens  [4] , 
leading to the heterogeneous distribution of atopic dis-
eases worldwide  [5] . The rise in atopy with urbanization 
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 Abstract 
 Background: The hygiene hypothesis suggests that parasit-
ic infections protect against allergic diseases by modulating 
the host’s immune responses. Experimental studies indicate 
that this protection depends on the intensity of parasitic in-
fection, but this observation has not been tested in human 
populations. The aim of this study is to investigate whether 
the intensity of  Schistosoma haematobium  infection is relat-
ed to atopic responses and whether this relationship differs 
between populations with distinct parasite transmission dy-
namics.  Methods: The study was conducted in two villages 
with different  Schistosoma haematobium transmission dy-
namics, i.e. high (n = 365) and low (n = 307) transmission. Al-
lergic reactivity to the common house dust mite  (Derma-
tophagoides pteronyssinus) was measured by skin prick tests 
and allergen-specific IgE and IgG4 quantified by enzyme-
linked immunosorbent assay. Atopic responses were related 
to current infection intensity and schistosome transmission 
levels.  Results: Schistosome infection intensity was nega-
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has been attributed to reduced exposure to pathogens and 
their products in childhood as a result of improved hy-
giene  [4] . In particular, helminth parasites are believed to 
induce regulatory immune responses that dampen atopic 
responses  [6] , but this remains controversial  [7, 8] . Ani-
mal studies have shown that only heavy, chronic hel-
minth infection provides protection against atopy  [9] , 
which would explain some of the conflicting results from 
human studies  [8, 10] . To date, despite the several elegant 
mechanistic studies in the mouse models of the relation-
ship between helminth infections and atopy  [11] , only a 
few of the hypotheses and mechanisms have been vali-
dated in human studies. In particular, there is a paucity 
of studies investigating the effects of heterogeneities in 
host and parasite genotype, parasite transmission dy-
namics and previous history of host infection.
 A meta-analysis of human epidemiological studies has 
suggested that in areas of high helminth (geohelminth) 
prevalence, the risk of allergy is decreased, whereas in ar-
eas of low prevalence this risk is increased  [12] . This high-
lights the importance of helminth infection levels in the 
epidemiological patterns of helminth and atopy in hu-
man populations.
 We therefore set out to investigate the effect of differ-
ent parasite transmission dynamics on atopic responses 
in human populations naturally exposed to  Schistosoma 
haematobium which causes urogenital schistosomiasis. 
To capture the dynamics of the relationship between hel-
minth infection and atopy, the study was conducted in 
two villages of differing schistosome transmission dy-
namics, i.e. low and high transmission areas, resulting in 
differences in current infection intensity as well as in the 
cumulative history of schistosome infection  [13, 14] . Skin 
prick reactivity to the house dust mite (HDM)  (Derma-
tophagoides pteronyssinus) – the most prevalent allergen 
in Zimbabwe  [15, 16] – as well as levels of schistosome-
specific and HDM-specific IgE and IgG4 antibody re-
sponses were related to schistosome infection intensity in 
the two villages.
 Materials and Methods 
 Study Design 
 The study was comparative, contrasting the levels of atopic 
responses in high- and low-schistosome infection villages. This 
comparative approach, used by us and in other studies  [14, 17–20] , 
is very powerful for studying disease and immunology patterns 
where the history of exposure to the pathogen cannot be sepa-
rated from age in lifelong residents of endemic areas. As previ-
ously published  [21] , Zimbabwe has low levels of geohelminths. In 
addition,  Schistosoma mansoni levels are also low in most regions 
of Zimbabwe  [22] , while  S. haematobium is the most prevalent 
helminth infection in Zimbabwe. In this study area, the preva-
lence of  S. mansoni was 2%, thus the study focused on  S. haema-
tobium  infection. Differences in infection levels reflect the differ-
ences in infection transmission rates and in the history of infec-
tion  [13] . Subjects in the high-infection village accumulated 
infection more rapidly, acquiring higher infection intensities at a 
younger age than their counterparts in the low-infection village 
 [13] .
 Study Area and Population 
 The study was conducted in two villages, Magaya and Chitate, 
in the Mashonaland East province of Zimbabwe where  S. haema-
tobium is endemic. The study villages are in close proximity with-
in a 10-km range of each other and villagers are of similar ethnic-
ity (Shona) and socioeconomic background (rural subsistence 
farmers). Safe water and sanitation coverage are equally poor in 
the villages (indicated by our questionnaire studies). The only ob-
vious difference in the villages is the seasonality of the rivers 
which provide habitats for schistosome intermediate-host snails.
 Magaya village is characterized by perennial rivers which lead 
to high transmission rates of schistosome parasites compared to 
Chitate village which is characterized by seasonal streams. In ad-
dition, households in Magaya are built along the rivers, whereas 
in Chitate they are more dispersed and are built further from the 
rivers. Human contact with water harboring cercariae, the infec-
tive stage of schistosomes, is frequent (assessed by questionnaire 
studies) in this area due to insufficient safe water and sanitation 
facilities.
 In 2002, a revised stratification based on a national parasite 
prevalence survey, Health Management Information Systems 
data, entomological data and expert opinion classified our study 
area under the sporadic transmission regions with low transmis-
sion  [23, 24]  meaning that this is a mesoendemic area for  Plasmo-
dium transmission and malaria  [25] .
 Ethical Statement 
 Permission to conduct the study was obtained from the Pro-
vincial Medical Director, institutional and ethical approval was 
received from the University of Zimbabwe and the Medical Re-
search Council of Zimbabwe, respectively. All participants had 
the aims and procedures of the project explained and written con-
sent was obtained before enrolment into the study, and all were 
offered treatment with the recommended dose (40 mg/kg of body 
weight) of the antihelminthic drug, praziquantel. For young chil-
dren, written consent was obtained from parents/guardians.
 Sample Collection 
 The gold standard method for detecting and quantifying 
schistosome infection is through microscopic enumeration of 
eggs excreted in stool or urine  [26] . Stool samples for the diagno-
sis of  S. mansoni  and geohelminths and urine specimens for the 
diagnosis of  S. haematobium infection were collected on 3 con-
secutive days and processed using standard procedures  [23, 24] . 
For infants unable to produce stool or urine samples on demand, 
an overnight sample was collected by the parent/guardian and 
submitted on the following day. Up to 5 ml venous blood was col-
lected from each participant in citrate tubes, which was used to 
obtain sera for antibody assays. Malaria status was determined by 
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blood smears and confirmed by a serological Paracheck dipstick 
(Orchid Biomedical systems).
 Inclusion Criteria 
 To be included in the study, participants had to (1) be lifelong 
residents of the village (assessed by questionnaire), (2) be free 
from the geohelminth,  S. mansoni , and  Plasmodium infections (7 
people were excluded on this criterion because they were  S. man-
soni- positive but none was positive for  Plasmodium infection, 
which is consistent with this area being mesondemic for  Plasmo-
dium transmission  [25] ), (3) not have previously received antihel-
minthic treatment (no one was excluded on this criterion), (4) pro-
vide urine and stool samples for helminth diagnosis and a blood 
sample for serological assays (107 people were excluded on this 
criterion because they did not provide either of the samples, see 
table 1a). A total of 672 individuals fulfilled the inclusion criteria 
and formed the study populations of Magaya (n = 365, age range 
3–86 years) and Chitate (n = 307, age range 1–86 years) described 
in  table 1 a.
 Skin Prick Test 
 Skin prick tests (SPTs) were conducted (on a small consenting 
population, n = 332) using 4 allergens prevalent in Zimbabwe  [15] : 
HDM, Grass mix,  Alternaria tenius and  Aspergillus fumigatus. 
Briefly, a drop of each allergen was placed on the upper side of the 
lower arm before the skin beneath the drop was pricked using a 
lancet. The skin was then wiped, and 15 min later, the size of the 
wheal diameter was measured whenever the skin reacted for a 
given allergen. Histamine and saline solutions (Diagenics Ltd) 
were used as positive and negative controls, respectively. Reac-
tions were considered positive if the wheal diameter was equal to 
or greater than the positive control.
 This procedure showed that allergy to the HDM was the most 
prevalent (67.8% of the positive reactions were due to HDM alone), 
consistent with previous studies from Zimbabwe  [15, 16] . There-
fore, serological assays focused on D. pteronyssinus -specific re-
sponses.
 Serology and Laboratory Assays 
 Levels of antibodies directed against parasite antigens were 
measured by indirect enzyme-linked immunosorbent assay (ELI-
SA) following published procedures  [13] using soluble  S. haema-
tobium adult-worm antigen (SWAP) and soluble egg antigen 
(SEA) from the Theodor Bilharz Institute (Egypt). The parasite 
strain is one used in previous epidemiological studies  [25, 26] . 
Mite-specific responses were measured by ELISA using natural 
affinity-purified  D. pteronyssinus Der p 1 allergen from Indoor 
Biotechnologies. Microtiter plates were coated overnight at 4   °   C 
with 50   l/well of Der p 1 allergen in 5   g/ml carbonate-bicar-
bonate buffer. Serum samples were diluted at 1: 10 and the second-
ary antibodies, anti-human horseradish peroxide conjugated IgE 
(Sigma) and IgG4 (the binding site) at 1: 1,000. The substrate 2, 2  -
azino-bis-(3-benzthiazoline-6-sulfonic acid) (Southern Biotech) 
was used for the colorimetric reaction and the optical density read 
at 405 nm. All sera were assayed in duplicate and a pool of sera 
from 6 individuals presenting with the highest skin-prick reactiv-
ity was included on each plate to serve as a positive control. A 
blank control containing no sera was included on each plate (in 
duplicate) and the background absorbance of reagents in the ab-
sence of serum was subtracted from all readings.
 Statistical Analysis 
 Schistosome infection prevalence and intensity were com-
pared between the 2 villages by Pearson   2 test and analysis of 
variance (ANOVA), respectively. Age was categorized into 5 
groups ( table 1 ). The ANOVA used sequential sums of squares to 
calculate the mean squares to derive the test statistic. These allow 
the hierarchical decomposition of the sources of variation in the 
dependent variable, so that the effects of the preceding variable 
on the test variable are taken into account before testing for the 
variable of interest  [19] . In this way, they allow for confounding 
variables before testing for the effects of the variable of interest. 
This approach has been used to test for the relationship between 
schistosome infection and immune responses or other markers of 
immunity or pathology, while allowing for the potential con-
founding effects of the sex and age of the host  [27] .
 The effect of mite-specific antibodies on the SPT was assessed 
by ANOVA using sequential sums of squares to account for the 
effects of host age, sex, village of residence and infection intensity 
 [28] .
 A binary stepwise logistic regression was used to determine the 
relationship between SPT status and antibody levels with age, sex, 
village of residence and infection intensity included in the model.
 Following exploratory plots, the hypothesis that helminth in-
fection is negatively associated with atopy was tested using a 
1-tailed Pearson correlation analysis between the SPT results and 
infection intensity while controlling for the effects of host age, 
sex and village of residence. To test whether this association oc-
curs at the immunological level, the same correlation analysis 
was conducted relating antibody levels to infection intensity in 
each village. The effect of infection intensity on antibody re-
sponses (Der p 1- and schistosome-specific) was determined by 
multivariate analysis using sequential sums of squares, entering 
the variable ‘infection intensity’ last in the model  [28] .   -coeffi-
cients (for the direction of infection-antibody relationship) were 
calculated using linear regression analysis on residuals saved af-
ter accounting for the variations due to age, sex and village. All 
statistical analyses were conducted using PASW statistics (ver-
sion 17; formerly called SPSS) and values of p  ! 0.05 were consid-
ered significant.
 Results 
 S. haematobium Infection Levels Differ Significantly 
between the Two Villages 
 Schistosome infection levels were significantly higher 
in Magaya than Chitate with a prevalence of 45.4 versus 
8.5% (  2 = 111.4, d.f. = 1, p  ! 0.001) and mean infection 
intensity of 26.3 eggs/10 ml versus 0.755 eggs/10 ml 
(F 1, 662 = 92.75, p  ! 0.001), respectively. When partitioned 
by age, there were significant differences in infection lev-
els in the two areas in younger age groups ( fig. 1 ). Infec-
tion peaked at a higher level and at an earlier age in Ma-
gaya ( fig. 1 ), a phenomenon referred to as peak shift  [29] 
and confirmed by a significant age and village interaction 
(F 4, 662 = 5.938, p  ! 0.001)  [13] .
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 Antibody Profiles for Schistosome- and
Der p 1-Specific Responses 
 Antischistosome adult worm IgE and IgG4 (absorben-
cies) were significantly higher in the high-transmission 
area compared to the low-transmission area ( table  2 ). 
Only IgG4 responses directed against the egg stage of the 
parasite differed between the two villages, being also 
higher in the high-transmission area. Neither of the par-
asite-specific IgE:IgG4 ratios differed between the two 
areas ( table 2 ). Anti-adult worm IgE and IgG4 responses 
increased with age and rose faster in the high-transmis-
sion area compared to the low-transmission area ( fig. 2 ) 
and exhibited a peak shift in these responses. Amongst 
the Der p 1-specific responses, IgG4 levels were higher in 
the high-transmission area resulting in significantly low-
er IgE:IgG4 ratio in this village compared to the low-
transmission village ( table 2 ).
 SPT Reactivity Is Related to Allergen-Specific IgE and 
IgG4 Levels 
 Overall, the prevalence of positive SPT was 17.7% (95% 
CI 3.96–40.1) but 67.8% (95% CI 13.4–147.2) of SPT-posi-
tive individuals were sensitized to the HDM. Initial anal-
yses (univariate ANOVA) confirmed that the severity of 
Table 1. S tudy population description
a  Demography and socioeconomic status in the study areas
Magaya (HTA) Chitate (LTA)
Number of participants (baseline) 442 344
Mean age, years (range) 11.4 (3–86) 18.5 (1.5–86)
Sex ratio (M/F) 0.825 (199/241) 0.57 (127/221)
Ethnic group Shona Shona
Socioeconomic status rural subsistence farmers rural subsistence farmers
S. haematobium prevalence 52.94% (95% CI 48–57.67) 8.6% (95% CI 5.9–12.1)
S. haematobium intensity, eggs/10 ml (range) 44.79 (0–859), SEM = 5.654 0.958 (0–70.3), SEM = 0.2723
S. mansoni cases (excluded) 6 cases (7–13 years old) 1 case (69 years old)
Malaria prevalence 0% 0%
STH prevalence 0% 0%
No urine sample provided (excluded) 16 cases (3–26 years old) 2 cases (unknown age)
No blood sample provided and/or 
no age record (excluded) 55 34
Total number of participants included 365 307
SPT sampled 26 (3–65 years old, mean infection =
2.69 eggs/10 ml, range 0–22 eggs/10 ml)
306 (1.5–86 years old, mean infection = 
0.758 eggs/10 ml, range 0–30 eggs/10 ml)
b  S. haematobium infection levels by age in the selected populations
Age group
years
Magaya (HTA) Chitate (LTA) C omparison (statistics)
Infection 
intensity range 
(sample size)
Infection 
intensity
mean (SEM)a
Infection 
prevalence, %
(95% CI)b
Infection
intensity range 
(sample size)
Infection 
intensity 
mean (SEM)
Infection 
prevalence, %
(95% CI)
Prevalen ce
2 and
(p  value)
Infection 
intensity F
and (p value)
1–5 0–458 (47) 28.3 (13.5) 32 (20–50) 0–0.3 (38) 0.009 (0.0088) 2.6 (0.07–14) 11.35 (<0.001) 15.95 (<0.001)
6–10 0–481 (180) 20.6 (5.1) 44.4 (40-50) 0–27.5 (103) 0.67 (0.3) 8.7 (4–20) 42.8 (<0.001) 39.39 (<0.001)
11–15 0–692.7 (85) 42.5 (12.1) 60 (50–70) 0–20 (55) 0.99 (0.49) 12.7 (5–20) 34.05 (<0.001) 46.5 (<0.001)
16–20 0–50.7 (13) 5.8 (4.1) 30.7 (10–60) 0–25.7 (16) 2.5 (1.63) 25 (7–50) 0.115 (0.734) 0.021 (0.885)
21 and above 0–3.5 (17) 0.3 (0.2) 17.7 (4–40) 0–30.3 (75) 0.91 (0.48) 6.7 (2–15) 4.04 (0.044) 0.002 (0.962)
Overall 0–692.7 (365) 26.3 (4.45) 45.2 (40–50.5) 0–30.3 (307) 0.755 (0.21) 8.5 (5.61–12.16) 111.4 (<0.001) 92.75 (<0.001)
Bas eline variables (a) and infection levels by age groups in the selected populations (b) are shown for the 2 villages. Statistical results of 2 analysis 
and ANOVA on the prevalence and infection intensity, respectively, are presented for each age group and significant p values are highlighted in bold.
CI = Confidence interval; HTA = high-transmission area; LTA = low-transmission area; SEM = standard error of the mean; STH = soil-transmitted 
helminths.
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the SPT reactivity to HDM was significantly associated 
with the levels of Der p 1 IgE antibodies (F 1, 321 = 37.26,
p  ! 0.001), and the interaction between Der p 1-specific 
IgE and IgG4 (F 1, 321 = 5.1, p = 0.025). Furthermore, SPT-
positive people had significantly higher Der p 1-IgE and 
slightly higher Der p 1-IgG4 antibody titers (absorbencies) 
compared to SPT-negative people ( fig. 3 ), as determined 
by stepwise logistic regression analysis (Wald   2 = 11.484, 
d.f. = 1, p = 0.001 and Wald   2 = 1.573, d.f. = 1, p = 0.21, 
respectively, for IgE and IgG4 mean absorbencies).
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 Fig. 1. Prevalence and infection intensity according to age in the 
study area. Infection intensity ( a ) and prevalence ( b ) are plotted 
against age groups in the high-transmission (– – –) and the low-
transmission area (––––). Bars represent standard error of the 
means for infection intensity and 95% CI for the prevalence.  *  p  ! 
0.05 and  * *   p  ! 0.01 represent significant differences in each 
group between the two villages. 
Table 2. R esults from a multivariate analysis of the effects of age, sex, village and infection intensity on antibody levels and ratio
Dependent variable Sex Age Village
(comparison)
Infection intensity
F and () values
Age and village 
interaction
Infection and 
village interaction
Antischistosome responses
SWAP-IgE 17.769 (M>F)** 6.446** 22.648 (H>L)** 20.782 (0.155)** 3.061* 0.778
SWAP-IgG4 28.019 (M>F)** 9.478** 20.055 (H>L)** 49.113 (0.233)** 3.54** 0.139
SWAP-IgE/IgG4 2.450 (F>M) 1.895 1.014 (L>H) 4.948 (–0.076)* 2.558* 0.001
SEA-IgE 16.520 (M>F)** 14.299** 3.185 (L>H) 10.749 (0.112)** 1.804 5.177*
SEA-IgG4 21.685 (M>F)** 15.090** 42.185 (H>L)** 181.472 (0.416)** 1.889 8.324**
SEA-IgE/IgG4 0.026 (M>F) 2.303 22.963 (L>H)** 21.026 (–0.157)** 1.27 0.096
Antiallergen responses
Der p 1-IgE 10.769 (F>M)** 5.270** 1.013 (L>H) 5.673 (-0.079)* 3.81** 0.354
Der p 1-IgG4 6.178 (M>F)* 4.711** 15.219 (H>L)** 0.527 (–0.024) 1.195 0.025
Der p 1-IgE/IgG4 11.474 (F>M)* 0.806 11.460 (L>H)** 4.405 (–0.072)* 1.856 0.853
F values from a multivariate analysis determining the effects 
of different variables on the levels of parasite and allergen-specif-
ic antibody responses. The effects of infection intensity were de-
termined after allowing for the effects of a host’s age, sex and vil-
lage of residence by sequential sums of squares. The -coefficients 
from a linear regression are also shown for the direction of the 
relationship ‘infection-antibody’. Degrees of freedom: 1 for sex, 
village and infection; 4 for age; the total for the error was 660. F 
values with significant p values (i.e. * p < 0.05 and ** p < 0.01) are 
highlighted in bold.
F = Female; H = high-transmission village; L = low-transmis-
sion village; M = male; SEA= soluble egg antigen; SWAP = soluble 
worm antigen preparation.
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 Atopic Responses Are Negatively Correlated with 
Schistosome Infection Intensity 
 The prevalence of sensitization to HDM (% of people 
positive for the SPT test) was higher in the low-infection 
area (12.4%, 95% CI 3.48–29.1) than in the high-infection 
area (7.7%, 95% CI 6.74–32.8) and SPT-negative people 
had higher levels of schistosome infection, though these 
differences were not statistically significant. However, 
SPT wheal size was significantly inversely related to  S. 
haematobium infection intensity after allowing for the 
variations due to age, sex and village of residence ( fig. 4 ). 
An analysis to determine factors affecting levels of Der p 
1-specific antibodies showed that after allowing for sex, 
age and village of residence, schistosome infection inten-
sity negatively affected levels (absorbencies for all indi-
viduals) of Der p 1-specific IgE, but not IgG4, resulting in 
a significant effect on the ratio Der p 1-IgE:IgG4 ( table 2 ). 
This analysis also showed that levels of these two vari-
ables differed between the two villages. Therefore, cor-
relation analyses were conducted to determine the rela-
tionship between Der p 1 responses (absorbencies for all 
individuals) and infection intensity in each of the villages 
(after allowing for the confounding effects of sex and 
age). This showed that the correlation between infection 
intensity and the levels of Der p 1-specific IgE and the 
ratio Der p 1-specific IgE:IgG4 was significant only in the 
high-transmission village but not in the low-transmis-
sion village ( fig. 5 a). This contrasted with schistosome-
specific responses, where although there were differences 
in the magnitude of some of the responses between the 
two villages ( table 2 ), the relationship between the anti-
bodies and infection intensity was similar in the two vil-
lages ( fig. 5 b, c).
 The analyses suggested that the lack of a relationship 
between schistosome infection intensity and Der p 1 an-
tibodies and their ratio may be due to the overall lower 
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 Fig. 5. Correlations between schistosome-specific:mite-specific 
antibody ratio and infection intensity. Residuals (after controlling 
for age and sex) of IgE, IgG4 and IgE/IgG4 against Der p 1 ( a ), 
SWAPs ( b ) and SEAs ( c ) are plotted against infection intensity 
(log-transformed) for Magaya (high-transmission area) and Chi-
tate (low-transmission area). One-tailed Pearson correlations 
were performed. Correlations significant at p  ! 0.05 are high-
lighted in bold. Resid = Residual.  
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levels of infection in the low-infection area (interaction 
between infection and village is not significant in  table 2 ). 
Therefore, the relationship between schistosome infec-
tion intensity and anti-mite antibody responses (absor-
bencies for all individuals) was compared in people with 
similar levels of infection (0–30 eggs/10 ml urine) in the 
high-transmission village, controlling for variations due 
to host age and sex. This showed that at these low levels 
of infection, there was no significant correlation between 
infection intensity and Der p 1-specific antibodies (r = 
–0.089, p = 0.062 for IgE and r = –0.074, p = 0.095 for 
IgE:IgG4).
 Discussion 
 This study compared the effect of current schistosome 
infection and that of the cumulative history of infection 
on atopic responses in two villages of different schisto-
some transmission dynamics. Differences in these dy-
namics were confirmed by the differences in schistosome 
infection intensity and the existence of peak shifts  [29] . 
Moreover, we demonstrated the previously described in-
verse relationship between infection intensity and the ra-
tio IgE:IgG4 against the SEA and SWAP in both villages. 
This ratio has been associated with the development of 
protective immunity against schistosome infection/rein-
fection  [30, 31] . In this study, the relationship was signif-
icant in the high but not in the low-transmission village. 
This supports previous comparative studies showing that 
protective immunity develops as a function of cumula-
tive history of infection and will thus develop faster in 
areas of higher transmission compared to areas of lower 
transmission  [19] .
 The majority of SPT-positive participants were sensi-
tized to HDM compared to the other allergens (molds 
and grass) and the overall prevalence of the HDM sensi-
tization (12%) was comparable to that previously report-
ed for Zimbabwean populations, and is consistent with 
documented levels of atopy from other African countries 
 [16, 27, 32] . The low-infection area was overrepresented in 
the participants surveyed for the SPTs. However, by al-
lowing for the potential confounding effects of residential 
village in the statistical analyses, it meant that the rela-
tionship between schistosome infection intensity and 
SPT status could be analyzed regardless of village of resi-
dence. Furthermore, the SPT participants had compara-
ble infection ranges in the two villages, of 0–22 versus 
0–30, i.e. within the mild infection range as classified by 
the World Health Organisation, which meant the analy-
ses compared people with similar infection levels across 
the same infection range for the SPT versus infection in-
tensity aspect of the study.
 In this study, mite-specific IgE levels (absorbencies for 
all individuals) were positively correlated with the SPT 
reactivity to mite allergens, consistent with published re-
ports  [33] . Mean IgG4 levels (absorbencies) were higher, 
though not significantly so, in SPT-positive compared to 
SPT-negative people. The role of IgG4 in allergic condi-
tions is still poorly understood, but the high levels of both 
IgE and IgG4 in the SPT-positive participants could be 
related to the fact that IgE-inducing allergens are also ef-
ficient IgG4 inducers  [34] . SPT reactivity was negatively 
associated with S. haematobium  infection as reported in 
the Gabon  [10] . A comparison of Der p 1-specific anti-
body responses showed significant differences in levels of 
IgG4 but not IgE in the two villages together, with a sig-
nificant difference in the IgE:IgG4 ratio. Nonetheless, 
IgE but not IgG4 was significantly inversely associated 
with schistosome infection intensity, and consequently, 
the ratio IgE:IgG4 was also inversely associated with 
schistosome infection. It seems as though the IgG4 re-
sponse in this instance was modulating the pathological 
effects of the IgE, a concept which is important in allergy 
immunotherapy  [35] .
 Differences were observed in the schistosome-anti-
Der p 1 antibody relations between the two villages: there 
was no association between infection intensity and Der p 
1-specific IgE (and the ratio IgE:IgG4) antibody respons-
es (absorbencies) in the low-transmission area but a sig-
nificant negative association in the high-transmission 
area. This finding that areas of different schistosome en-
demicity exhibit differences in the relationship between 
antimite antibody responses and infection intensity may 
explain findings from a recent meta-analysis which 
showed that results on the relationship between schisto-
some infection and atopy were heterogeneous  [36] . The 
fact that people in the low-infection area mounted similar 
antischistosome IgE and IgG4 responses (albeit at a lower 
level) indicates that there was no impairment in their 
ability to mount IgE and IgG4 responses. One potential 
reason for the lack of an association between their aller-
gen-specific antibody responses (absorbencies) and schis-
tosome infection was the overall low level of schistosome 
infection. To investigate this, the relationship between 
schistosome infection intensity and antimite antibody re-
sponses (absorbencies) was compared in people with sim-
ilar infection levels in both villages. This showed that at 
such low levels of infection (0–30 eggs/10 ml of urine), 
there was no significant correlation between infection in-
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